Navigation Links
U.S. FDA Grants Priority Review to Bayer's Radium Ra 223 Dichloride NDA for Castration-Resistant Prostate Cancer with Bone Metastases
Date:2/12/2013

WAYNE, N.J., Feb. 13, 2013 /PRNewswire/ -- Bayer HealthCare announced today that the New Drug Application (NDA) for its investigational oncology compound Radium Ra 223 Dichloride (radium-223) has been accepted for filing and granted priority review by the U.S. Food and Drug Administration (FDA). The application is currently under review for the treatment of castration-resistant prostate cancer (CRPC) patients with bone metastases.

"We are pleased the FDA has granted priority review of the radium-223 new drug application for the treatment of patients with castration-resistant prostate cancer that has metastasized to the bones. Receiving this designation marks another positive milestone for radium-223 and underscores Bayer's ongoing commitment in oncology," stated Pamela A. Cyrus , MD, Vice President and Head of U.S. Medical Affairs, Bayer HealthCare Pharmaceuticals.

The FDA grants priority review to medicines that provide a treatment where little or no adequate therapy exists. Under the Prescription Drug User Fee Act (PDUFA), the FDA aims to complete its review within six months of the 60-day filing receipt of the NDA submission (eight months total), rather than the standard 12-month review cycle. 

In September 2009, Bayer signed an agreement with Algeta ASA (Oslo, Norway) for the development and commercialization of radium-223. Under the terms of the agreement, Bayer will develop, apply for health authority approvals worldwide, and commercialize radium-223 globally. Algeta will co-promote radium-223 with Bayer in the U.S.

About Radium Ra 223 Dichloride

Radium Ra 223 dichloride (radium-223), formerly referred to as radium-223 chloride, is an investigational alpha particle-emitting pharmaceutical in development for CRPC patients with bone metastases.

Radium-223 is an investigational agent and is not approved by the FDA, the Europe
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Afraxis Grants Exclusive Global License to Genentech
2. FDA Grants Soligenix Fast Track Designation for OrbeShield(TM) for the Reduction of Mortality Associated with Gastrointestinal Acute Radiation Syndrome (GI ARS)
3. New Jersey Health Foundation Awards First Two Innovation Stage Funding Grants
4. Artemis Diagnostics awarded two grants from Technology Strategy Board to develop cancer imaging technology
5. New Jersey Health Foundation Commits $2 Million to Fund Grants
6. FDA Grants Orphan Drug Status To Morphoteks Amatuximab (MORAb-009)
7. FDA Grants Soligenix Fast Track Designation for SGX203 for the Treatment of Pediatric Crohns Disease
8. ViiV Healthcare commits nearly £4M in Positive Action for Children Fund grants for programmes focused on alleviating burden of HIV on women and children
9. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
10. As Global Telemedicine Market Reaches $2.5 Billion, Industry Leaders Gather in San Diego to Discuss Grants, Funding, Vendor Selection, Credentialing, and More
11. EMA Grants Orphan Designation to Edison Pharmaceuticals for EPI-743 for Treatment of Leigh Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 2014  Over 100 million adults suffer from chronic ... pain daily. Chronic and acute pain dramatically impacts quality ... to fulfill the need for non-surgical, interventional solutions and ... On October 28th, a new pain management center ... community.  This new facility boasts cutting edge ...
(Date:11/26/2014)... 26, 2014 Zynerba Pharmaceuticals , Inc., ... innovative transdermal synthetic cannabinoid treatments, today announced that the ... Healthcare Conference 2014. The conference will be held December ... New York . Zynerba,s Chairman and ... pm on Tuesday, December 2. To listen ...
(Date:11/26/2014)... -- According to the new research ... Battery, Pneumatic), by Product (Drill, Saw, Stapler, Reamer, ... (Orthopedic, ENT, Oral, Thoracic, Neurology) - Global Forecasts ... Instruments Market is estimated to be worth around ... expected to grow at a moderate CAGR during ...
Breaking Medicine Technology:New Pain Management Center Opens in Cumberland, Md. 2Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 4
... GRONINGEN, Netherlands , July 26 ... organization providing testing services to support preclinical and clinical ... of Xendo Drug Development BV (XDD), headquartered in Groningen, ... organization (CRO), will be known as QPS Netherlands BV ...
... Harco Metal Products (Harco), an industry leader in tube ... contract to manufacture MediGLIDER™ products for ConMediSys. , ... ConMediSys, the developer of safety products ... risk and cost associated with staff injuries caused by physically lifting ...
Cached Medicine Technology:QPS Announces the Acquisition of Xendo Drug Development 2QPS Announces the Acquisition of Xendo Drug Development 3QPS Announces the Acquisition of Xendo Drug Development 4Harco Partners With ConMediSys to Deliver Patient Safety and Equipment Integrity 2
(Date:11/27/2014)... 2014 This is a professional and ... Bronchoscopes industry with a focus on the Chinese market. ... of the Bronchoscopes manufacturers and is a valuable source ... in the industry. , Firstly, the report provides a ... and manufacturing technology. Then, the report explores the international ...
(Date:11/27/2014)... The American Society for Clinical Pathology (ASCP) announced ... honor of World AIDS Day 2014. On Nov. 25, ASCP ... icon and infographic designed to generate public awareness about World ... , ASCP has asked members to replace their Facebook, Twitter, ... Tested. Find a cure.” icon and share the accompanying infographic ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 According to ... those companies looking to break into the surgical ... medical specialties, other than the MIS field dominated by ... of the U.S. surgical robotics market by 2020. ... explains Dr. Kamran Zamanian, CEO and President of iData. ...
(Date:11/27/2014)... 27, 2014 In a world ... to sleep has lessened, and due to the ... quality of sleep has eroded. According to Web ... the job (Reference: http://www.webmd.com/sleep-disorders/features/sleep-deprivation-workplace ). This remarkably ... by an incalculable amount, leading not only to ...
(Date:11/27/2014)... 27, 2014 "As a nurse I ... effects of urinary incontinence," said an inventor from Whiting, ... this specialized accessory to prevent leakage and keep them ... absorb urine leakage. This prevents stains on pants, skirts ... The pad ensures that the individual has time to ...
Breaking Medicine News(10 mins):Health News:Bronchoscopes Industry 2019 Forecasts for Global and China Region in New Research Report at ReportsnReports.com 2Health News:Bronchoscopes Industry 2019 Forecasts for Global and China Region in New Research Report at ReportsnReports.com 3Health News:ASCP Launches Social Media Campaign in Honor of World AIDS Day 2Health News:U.S. Robotic Surgery Market Set to Diversify and Grow: Intuitive Surgical’s ‘da Vinci’ Robot Revenues to Increasingly Rely On Procedures and Services 2Health News:Research Shows Surprising Number of US Workers Affected by Lack of Sleep 2
... The following was released today by the Center to Expose ... to Expose and Close Animal Factories (CECAF) will hold a ... caused by animal "factories." Among the topics will be ... in Veracruz, Mexico. Officials in Mexico are looking at ...
... product designer to open industry,s best-attended and most ... Orlando, Florida, October 31 - November 3, 2009. ... of HEALTHCARE DESIGN magazine, and The ... education, and advocacy organization, today announced that architect ...
... The New Investigator Career Highlight Forum at the ninth ... 4, 2009 at the John B. Hynes Convention Center ... innovative research in transplantation. These promising investigators have ... Surgeons (ASTS) or the American Society of Transplantation (AST). ...
... 29 Millennium Dental Technologies, Inc. has issued ... statement on the use of lasers in dentistry. ... misleading, and scientifically unsubstantiated, especially as it relates ... protocol. http://www.ada.org/prof/resources/positions/statements/lasers_final.asp ...
... reading disabilities , , WEDNESDAY, April 29 (HealthDay News) -- ... located in the brain,s visual word form area, U.S. ... 30 issue of Neuron , offers new insight ... of reading disabilities. , "Although some theories of reading, ...
... immunotherapy for the treatment of allergy symptoms caused by ... used in Europe. It should be employed to further ... symptoms are largely undertreated, according to an invited article ... Neck Surgery . A response to the article, published ...
Cached Medicine News:Health News:Celebrated Architect Michael Graves to Keynote HEALTHCARE DESIGN.09 Conference 2Health News:Celebrated Architect Michael Graves to Keynote HEALTHCARE DESIGN.09 Conference 3Health News:Celebrated Architect Michael Graves to Keynote HEALTHCARE DESIGN.09 Conference 4Health News:American Transplant Congress 2009: New Investigator Forum Presents Cutting Edge Research 2Health News:LANAP Inventors Call ADA's Laser Position Statement Flawed 2Health News:LANAP Inventors Call ADA's Laser Position Statement Flawed 3Health News:LANAP Inventors Call ADA's Laser Position Statement Flawed 4Health News:Imaging IDs Brain Neurons With Preference for Real Words 2Health News:Sublingual immunotherapy for inhalant allergies deserves deeper consideration 2